CTI BIOPHARMA AND FRED HUTCHINSON CANCER RESEARCH CENTER ANNOUNCE INTERNATIONAL RESEARCH FELLOWSHIP TO SUPPORT INNOVATIVE BLOOD-RELATED CANCER RESEARC

Protocollo
6519
Comunicato
20151001_6519.pdf
Azienda
CTI BIOPHARMA
Tipo
Comunicato
SDIR
SDIRNIS
Lingua
ENG
Data creazione
Data ricezione SDIR
Data diffusione SDIR
Mercato
Euronext Star Milan